NCT01615354View on ClinicalTrials.gov

A Study of Aleglitazar in Combination With Oral Contraceptive Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Healthy Volunteer
Interventions
DRUG

Aleglitazar

Multiple oral doses

DRUG

Microgynon®

Multiple oral doses

DRUG

Placebo

Multiple oral doses

Trial Locations (1)

M13 9WL

Manchester

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01615354 - A Study of Aleglitazar in Combination With Oral Contraceptive Healthy Volunteers | Biotech Hunter | Biotech Hunter